PREDOPERATsIONNAYa KhIMIOTERAPIYa PRI REZEKTABEL'NYKh METASTAZAKh KOLOREKTAL'NOGO RAKA V PEChENI
- Authors: Chernoglazova E.V1
-
Affiliations:
- Issue: No 8 (2014)
- Pages: 71-74
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/286941
- ID: 286941
Cite item
Open Access
Access granted
Abstract
Colorectal cancer (CR) is a leader in the morbidity and mortality from malignant tumors. Currently, along with chemotherapy, liver resection remains the only method allowing to achieve recovery in patients with colorectal liver metastases. Preoperative chemotherapy improves radicality of operation by reduction of metastases size and eradication of micrometastases. Moreover, the assessment of the drug-induced pathomorphism provides more reasonable choice of postoperative management. Several studies have shown an advantage of perioperative chemotherapy in resectable colorectal liver metastases. The role of preoperative chemotherapy, however, is not well-understood and requires further research.
Full Text
References
- Jemal А., Bray F., Center М.М., et al. Global cancer statistics. CA Cancer J. Clin. 2011; 61(2): 6990.
- Chau I., Cunningham D. Treatment in advanced colorectal cancer: what, when and how? Br. J. Cancer 2009; 100(11): 1704-70.
- Nordlinger B., Van Cutsem E., Rougier P., et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur. J. Cancer. 2007; 43(14): 2037-45.
- Pawlik T.M., Schulick R.D., Choti M.A. Expanding criteria for resectability of colorectal liver metas-tases. Oncologist. 2008; 13(1): 51-64.
- Schmoll H.J., Van Cutsem E., Stein A., et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann. Oncol. 2012; 23(10): 2479-516.
- Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative chemotherapy with FOLFOX4 and surgery us surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomized controlled trial. Lancet. 2008; 371: 1007-16.
- Sorbye H., Mauer M., Gruenberger T., et al. Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann. Surg. 2012; 255(3): 534-39.
- Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013; 14(12): 1208-15.
- Ciliberto D., Prati U., Roveda L., Barbieri V., Staropoli N., et al. Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trials. Oncol. Rep. 2012; 27(6): 1849-56.
- Adam R., Bhangui P., Poston G., et al. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann. Surg. 2010; 252(5): 774-87.
- Zhu D., Zhong Y., Wei Y., et al. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS One. 2014; 9(1): e86543. 1-6.
- Primrose J., Falk S., Finch-Jones M., et al. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. Lancet Oncol. 2014; 15(6): 601-11.
- Adam R., Pascal G., Castaing D., et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann. Surg. 2004; 240(6): 1052-61.
- Adam R., Wicherts D.A., de Haas R.J., et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J. Clin. Oncol. 2008; 26: 1635-41.
- Neumann U.P., Thelen A., Röcken C., et al. Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases. Surgery. 2009; 146(1): 52-9.
Supplementary files
